Patient characteristics and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban or vitamin K antagonists: real-world evidence from Italian administrative databases.
VALUE IN HEALTH（2018）
摘要
In this analysis, apixaban was associated with a lower risk of major bleeding compared with VKA.
更多查看译文
关键词
cardiology/cardiovascular,cohort studies,comparative effectiveness research
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要